nivalis.com nivalis.com

nivalis.com

Official Site of Nivalis Therapeutics, Inc.

With over 1,800 known mutations of the cystic fibrosis gene, Nivalis Therapeutics aims to provide treatments equally as unique. Learn more on the website.

http://www.nivalis.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR NIVALIS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.1 out of 5 with 9 reviews
5 star
4
4 star
2
3 star
3
2 star
0
1 star
0

Hey there! Start your review of nivalis.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

CONTACTS AT NIVALIS.COM

MARCHEX SALES LLC -THIS DOMAIN MAY BE FOR SALE- HTTP://WWW.ARCHEODOMAINS.COM/NIVALIS.COM?UTM_SOURCE=WHOIS

WHOIS AGENT

PO ●●●639

C/O N●●●●●S.COM

KIR●●●AND , WA, 98083

US

1.88●●●●5109
1.42●●●●4730
WH●●●●●●●●@WHOISPRIVACYPROTECT.COM

View this contact

MARCHEX SALES LLC -THIS DOMAIN MAY BE FOR SALE- HTTP://WWW.ARCHEODOMAINS.COM/NIVALIS.COM?UTM_SOURCE=WHOIS

WHOIS AGENT

PO ●●●639

C/O N●●●●●S.COM

KIR●●●AND , WA, 98083

US

1.88●●●●5109
1.42●●●●4730
WH●●●●●●●●@WHOISPRIVACYPROTECT.COM

View this contact

MARCHEX SALES LLC -THIS DOMAIN MAY BE FOR SALE- HTTP://WWW.ARCHEODOMAINS.COM/NIVALIS.COM?UTM_SOURCE=WHOIS

WHOIS AGENT

PO ●●●639

C/O N●●●●●S.COM

KIR●●●AND , WA, 98083

US

1.88●●●●5109
1.42●●●●4730
WH●●●●●●●●@WHOISPRIVACYPROTECT.COM

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
2003 May 12
UPDATED
2014 June 13
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

DOMAIN AGE

  • 20

    YEARS

  • 11

    MONTHS

  • 23

    DAYS

NAME SERVERS

1
ns1.parklogic.com
2
ns2.parklogic.com

REGISTRAR

ENOM, INC.

ENOM, INC.

WHOIS : whois.enom.com

REFERRED : http://www.enom.com

CONTENT

SCORE

6.2

PAGE TITLE
Official Site of Nivalis Therapeutics, Inc. | nivalis.com Reviews
<META>
DESCRIPTION
With over 1,800 known mutations of the cystic fibrosis gene, Nivalis Therapeutics aims to provide treatments equally as unique. Learn more on the website.
<META>
KEYWORDS
1 application name
2 about nivalis
3 mission and values
4 leadership
5 history
6 nivalis science
7 platform
8 gsno and gsnor
9 lead clinical candidate
10 cystic fibrosis
CONTENT
Page content here
KEYWORDS ON
PAGE
application name,about nivalis,mission and values,leadership,history,nivalis science,platform,gsno and gsnor,lead clinical candidate,cystic fibrosis,disease,investors,newsroom,press releases,publications,explore our efforts,about us,leading innovation in
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Official Site of Nivalis Therapeutics, Inc. | nivalis.com Reviews

https://nivalis.com

With over 1,800 known mutations of the cystic fibrosis gene, Nivalis Therapeutics aims to provide treatments equally as unique. Learn more on the website.

INTERNAL PAGES

nivalis.com nivalis.com
1

About Our Clinical-Stage Pharma Company - Nivalis Therapeutics

http://www.nivalis.com/about

About Our Clinical-Stage Pharma Company - Nivalis Therapeutics. Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that are designed to preserve intracellular GSNO (S-nitrosoglutathione), an endogenous molecule with cell signaling effects that are implicated in the pathophysiology of cystic fibrosis (CF). The Company’s lead candidate, N91115 initially targets patients with the F508del mutation, the most common disease causing mutation in CF. Nivalis Thera...

2

Publications | Nivalis Therapeutics, Inc.

http://www.nivalis.com/newsroom/publications

Mar 18, 2016. Enhanced F508del-CFTR Modulation with S-nitrosoglutathione. Oct 7, 2015. The Pharmacokinetics of N91115 in Cystic Fibrosis Patients. Oct 7, 2015. Safety and Pharmacokinetics of N91115 in Patients with Cystic Fibrosis. May 15, 2015. A Novel Therapeutic Target in Asthma: Translational Evidence for Inhibition of. May 15, 2015. Enhanced CFTR modulation with a S-nitrosoglutathione reductase inhibitor. October 9, 2014. October 9, 2014. Safety, Tolerability, and Pharmacokinetics of the Intravenous.

3

Cystic Fibrosis | Nivalis Therapeutics, Inc.

http://www.nivalis.com/cystic-fibrosis-drugs

Cystic Fibrosis Nivalis Therapeutics, Inc. CF is a life-shortening genetic disease that affects an estimated 70,000 people worldwide, including approximately 65,000 in the United States and Europe. There is no known cure for CF and the predicted median age of survival in the United States is approximately 41 years. Nivalis Therapeutics is not responsible for the content on linked websites. The document you requested is located on the Journal of Applied Physiology. Return to Nivalis.com.

4

History of Nivalis Therapeutics, Inc.

http://www.nivalis.com/about/history

Nivalis began operations in 2008 with an initial focus on administering exogenous GSNO as a potential therapeutic agent in asthma and CF. We completed Phase 1 testing of an inhaled formulation of GSNO , and we applied for, and were granted, Orphan Drug designation related to the potential use of GSNO to treat CF in the United States. Nivalis Therapeutics is not responsible for the content on linked websites. The document you requested is located on the Journal of Applied Physiology.

5

Leadership team at Nivalis Therapeutics, Inc.

http://www.nivalis.com/about/leadership-team

President and Chief Executive Officer. David Rodman, M.D.,. Chief Medical Officer and Vice President of Discovery. R Michael Carruthers,. Sherif Gabriel, Ph.D.,. Vice President – Research and Discovery. Steven Shoemaker, M.D.,. Vice President – Clinical Research and Development / Medical Director. Howard Furst, M.D. Evan Loh, M.D., FACC, FAHA,. Frank Accurso, MD,. John P. Clancy, MD,. Cincinnati Children’s Hospital. Scott Donaldson, MD,. University of North Carolina. Benjamin Gaston, MD,.

UPGRADE TO PREMIUM TO VIEW 5 MORE

TOTAL PAGES IN THIS WEBSITE

10

SOCIAL ENGAGEMENT



OTHER SITES

nivalink.com nivalink.com

Nivalink - Weekend Getaways - Group Getaways - Holidays - International Travel

It’s free and takes about a minute. United States Of America. Saint Kitts And Nevis. Saint Pierre and Miquelon. Sao Tome and Principe. Turks And Caicos Islands. Wallis And Futuna Islands. Dadra and Nagar Haveli. By clicking Finish I agree to Nivalink’s Terms of Use. Send occasional information and offers about places I love to travel. Invalid email id or password. Please enter the email address you registered with and we will send you a confirmation mail to reset your password. To your address book.

nivalinna.net nivalinna.net

Nivalinnan pesu ja maatila-apu

Onko sinulla liikatarjontaa töistä? Et ehdi tai pysty tekemään kaikkea itse? Nivalinnan pesu ja maatila-apu. Vastaa ja tulee paikalle silloin kun tarvitset. Yrityksen palveluja käyttävät mm. maatilat, karjatilat ja muut teollisuustilat. Tilojen pesut ja imuroinnit. Myös muu maatalousapu. Kaikki työt tehdään ammattittaidolla, 18-vuoden työkokemuksella. Tarvittaessa, myös nopealla aikataululla. Käytössä ensiluokkaiset höyrypesuri (1921T. P 0400 43 12 63.

nivalis-aca.com nivalis-aca.com

Accueil

Bienvenue sur le site nivalis-aca.com. Bienvenue sur le site nivalis-aca.com. Bienvenue sur le site nivalis-aca.com. Bienvenue sur le site nivalis-aca.com. Bienvenue sur le site nivalis-aca.com. Bienvenue sur le site nivalis-aca.com. Créer de la visibilité.

nivalis-group.com nivalis-group.com

Nivalis Group

nivalis-kip.skyrock.com nivalis-kip.skyrock.com

Son Profil - Nivalis-Kip - Skyrock.com

Mot de passe :. J'ai oublié mon mot de passe. La position des blocs a été enregistrée. Ce profil t'a plu? Jeu 04 décembre 2014. Signe astro : Sagittaire. Poster sur mon blog.

nivalis.com nivalis.com

Official Site of Nivalis Therapeutics, Inc.

Nivalis Therapeutics, Inc. Nivalis Therapeutics (formerly N30 Pharmaceuticals) is headquartered in Boulder, Colorado. Our company is small, but passionate and growing. We have transitioned from an early-stage company solely focused on preclinical exploration, to a clinical-stage company that is focused on translating bench-side science into patient benefit. Innovative Engineering in Cystic Fibrosis. Nivalis Therapeutics, Inc. Boulder, CO 80301. August 3, 2015. June 23, 2015. June 17, 2015. May 13, 2015.

nivalis.eu nivalis.eu

Nivalis

Enti pubblici e no-profit. Sulle strade di Dedalo. Dalla formazione alla valutazione. Consultorio leggero per bambini, giovani e famiglie a Milano. Nel tempo della crisi. Sostegno psicologico a imprenditori in crisi e alle loro famiglie. Interventi sociali: valutazione degli esiti. A CHI CI RIVOLGIAMO. Supporto clinico e psicoterapia. Enti pubblici e no-profit. Nivalis nasce da Arché. 20125 Milano Via Villa Mirabello 6. Albo Nazionale Cooperative Sociali A227881.

nivalis.hk nivalis.hk

Home | Nivalis Partners Limited

Nivalis is focused on Asian equity and fixed income markets. We also manage and advise multi-assets global portfolios on a unconstrained basis. Based in Hong Kong, Nivalis is fully independent and owned by its management. Nivalis is licensed with the Securities and Futures Commission (SFC) to carry out regulated activities (type 1, 4 and 9). The company is targeting professional investors as per the definition in the Securities and Futures Ordinance.

nivalis.ie nivalis.ie

CD DVD CDR CD-R DVD-R DVD+R Ireland Nivalis Limited

Nivalis Limited Ireland 2008. For further details on all products and services please contact us at:.

nivalis.jp nivalis.jp

気分は き・の・こ

2018年4月10日 ヤケノヒメイタチタケ、ツバナシヤナギマツタケ、タカネイタチタケ、ヒメヒガサヒトヨタケ、 ミヤママスタケ、Peziza subisabellina、 peziza apiculataを追加しました。 2015年4月 2日 カキシメジ、アオイヌシメジ、タマゴタケモドキ、ニオイドクツルタケ、シロトマヤタケ、 オオツガタケ、オオウスムラサキフウセンタケ、カワムラフウセンタケ、Cortinarius montanus、 Cortinarius croceus、Cortinarius elegantiorをに追加しました。 2015年3月26日 Lactarius pterosporus、Lactarius lacunarum、ドクベニタケ、モミジタケ、トサカイボタケを 追加しました。 2015年3月23日 シロアミタケ、アラゲカワラタケ、シラガツバフウセンタケ、ワサビタケ、ニッケイタケ、 Entoloma porphyrogriseum を追加しました。 2015年3月9日 Agaricus subperonatus 和名なし 、ウスキモリノカサ、ムツノウラベニタケをしました。

nivalis.nl nivalis.nl

Nivalis – Nivalis

Wir sind Nivalis, we know nothing. What makes this single-page WordPress theme unique. Use this section to showcase important details about you. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla nec massa enim. Aliquam viverra at est ullamcorper sollicitudin. Proin a leo sit amet nunc malesuada imperdiet pharetra ut eros. 4 Dezember 2015, 16:36.